The daily dose most likely to prevent harmful side effects in the general population is known as a Tolerable Upper Intake Level (UL)
The authors reported that AOD-9604 stimulated lipolysis in isolated adipocytes and that chronic daily treatment in obese Zucker rats produced reductions in body weight gain of more than 50% relative to untreated controls over the treatment period, without effects on insulin sensitivity or IGF-1 levels [3]
These include increased energy levels, improved cognitive function, better moods, and reduced risk of certain diseases
Detailed Certificates of Analysis (CoA) are available to support experimental reproducibility and confirm molecular weight and purity
Tesofensine works by inhibiting the reuptake of dopamine, norepinephrine, and serotonin, leading to appetite suppression and increased satiety
By activating GLP-1 receptors, semaglutide suppresses appetite, reduces hunger cravings, and lowers calorie intake